Clinical trials
Insulinoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2014 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 4 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Guangxi Medical University | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulinoma | 8 |
| Adenoma, Islet Cell | 1 |
| Congenital Hyperinsulinism | 1 |
| Gastrinoma | 1 |
| Glucagonoma | 1 |
| Lung Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Nesidioblastosis | 1 |
| Somatostatinoma | 1 |
Trials
Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.